which glp 1 agonists have cardiovascular benefit Updated evidence on and renal effects of GLP-1 receptor and combination therapy with SGLT2 inhibitors and finerenone: a narrative review and perspectives | Cardiovascular Diabetology Glucagon-like peptide-1 (GLP-1) receptor agonists

These metabolites exert pharmacological effects by protecting hepatocytes from damage, regulating hepatic lipid metabolism, improving insulin sensitivity, and resisting oxidative stress, collectively contributing to the mitigation of MASLD

Secondary searches were performed using Google Scholar and regulatory sources, e.g., US Food and Drug Administration (FDA) labels and European Medicines Agency (EMA) reports, to capture gray literature and pharmacovigilance data

Convinced it's worth trying

The 6 players on the team are testosterone, estrogen, progesterone, pancreas, thyroid and adrenal

For more information about how BC Guidelines are developed, refer to the GPAC Handbook available at BCGuidelines.ca: GPAC Handbook